Basiliximab [clinicaltrials_resource:62683ae5f4103fb29d38329b10654510]
clinicaltrials:NCT00113269clinicaltrials:NCT00149890Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients [clinicaltrials:NCT00149994]Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF) [clinicaltrials:NCT00154232]clinicaltrials:NCT00154284Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant [clinicaltrials:NCT00188825]Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients [clinicaltrials:NCT00228020]An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. [clinicaltrials:NCT00235300]Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation [clinicaltrials:NCT00238901]Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids [clinicaltrials:NCT00239031]clinicaltrials:NCT00251004MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive [clinicaltrials:NCT00284921]Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids [clinicaltrials:NCT00284947]clinicaltrials:NCT00296244EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function [clinicaltrials:NCT00302497]An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation. [clinicaltrials:NCT00343226]clinicaltrials:NCT00369161clinicaltrials:NCT00378014Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients [clinicaltrials:NCT00409656]Basiliximab in Moderate to Severe Ulcerative Colitis [clinicaltrials:NCT00430898]clinicaltrials:NCT00434811clinicaltrials:NCT00468117clinicaltrials:NCT00468403Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation [clinicaltrials:NCT00492869]A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients [clinicaltrials:NCT00543569]clinicaltrials:NCT00555321Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation [clinicaltrials:NCT00563108]clinicaltrials:NCT00626015clinicaltrials:NCT00626483clinicaltrials:NCT00634920clinicaltrials:NCT00646425clinicaltrials:NCT00658320clinicaltrials:NCT00679042Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation [clinicaltrials:NCT00724022]Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance [clinicaltrials:NCT00752479]clinicaltrials:NCT00789308clinicaltrials:NCT00798785Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab [clinicaltrials:NCT00842699]clinicaltrials:NCT00890253Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation [clinicaltrials:NCT00903188]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Basiliximab [clinicaltrials_resource:62683ae5f4103fb29d38329b10654510]
Bio2RDF identifier
62683ae5f4103fb29d38329b10654510
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:62683ae5f4103fb29d38329b10654510
identifier
clinicaltrials_resource:62683ae5f4103fb29d38329b10654510
title
Basiliximab
@en
type
label
Basiliximab [clinicaltrials_resource:62683ae5f4103fb29d38329b10654510]
@en